Taysha Gene Therapies Inc Free Cash Flow Generation Index

Latest as of December 2022: 0.84x

Taysha Gene Therapies Inc free cash flow generation index. Taysha Gene Therapies Inc (TSHA) has a Free Cash Flow Generation Index of 0.84x as of December 2022. Free cash flow of $11.97 Million represents 1% of operating cash flow ($14.28 Million). Read Taysha Gene Therapies Inc (TSHA) financial obligations for a breakdown of total debt and financial obligations.

FCF Generation Index

0.84x
Free Cash Flow / Operating CF

Free Cash Flow

$11.97 Million
USD

Operating Cash Flow

$14.28 Million
USD

Capital Expenditures

$2.31 Million
USD

Free Cash Flow Generation Index of Taysha Gene Therapies Inc (2019–2019)

Free cash flow generation index of Taysha Gene Therapies Inc from 2019 to 2019. Historical FCF Generation Index trend for Taysha Gene Therapies Inc across 1 annual periods. Explore TSHA capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Taysha Gene Therapies Inc Free Cash Flow Generation Index by Year (2019–2019)

Taysha Gene Therapies Inc free cash flow generation index by year from 2019 to 2019. Year-by-year Free Cash Flow Generation Index for Taysha Gene Therapies Inc. For the full cash flow conversion analysis, see Taysha Gene Therapies Inc cash flow conversion.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2019 1.00x $135.00K $135.00K $82.00K —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).